Effects of cocktail therapy on cell proliferation and collagen I and TIMP-1 mRNA expression in rat hepatic stellate cells

World Chinese Journal of Digestology

Volumn 18, Issue 9, 2010, Pages 932-936

  Liao, Ming ^a   Li, Yan ^b   Shu, Wei ^a   Zhuo, Lang ^c  

^a GUANGXI MEDICAL UNIVERSITY   (China)

^b GUANGXI UNIVERSITY   (China)

^c INSTITUTE OF BIOENGINEERING AND NANOTECHNOLOGY   (Singapore)

Author keywords

Cocktail therapy; Gene expression; Hepatic stellate cell

Indexed keywords

COLLAGEN TYPE 1; EPIGALLOCATECHIN GALLATE; GENISTEIN; MESSENGER RNA; TAURINE; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; GENE EXPRESSION; MONOTHERAPY; NONHUMAN; RAT; STELLATE CELL;

EID: 77952396903     PISSN: 10093079     EISSN: None     Source Type: Journal    
DOI: 10.11569/wcjd.v18.i9.932     Document Type: Article

References (27)

1. Weng H, Mertens PR, Gressner AM, Dooley S. IFN-gamma abrogates profibrogenic TGF-beta signaling in liver by targeting expression of inhibitory and receptor Smads. J Hepatol 2007; 46: 295-303 (Pubitemid 44959156)
2. Son G, Iimuro Y, Seki E, Hirano T, Kaneda Y, Fujimoto J. Selective inactivation of NF-kappaB in the liver using NF-kappaB decoy suppresses CCI4-induced liver injury and fibrosis. Am J Physiol Gastrointest Liver Physiol 2007; 293: G631-G639 (Pubitemid 47435392)
3. Seki E, Brenner DA. Toll-like receptors and adaptor molecules in liver disease: update. Hepatology 2008; 48: 322-335 (Pubitemid 351975556)
4. Iimuro Y, Brenner DA. Matrix metalloproteinase gene delivery for liver fibrosis. Pharm Res 2008; 25: 249-258
5. Dooley S, Hamzavi J, Ciuclan L, Godoy P, Ilkavets I, Ehnert S, Ueberham E, Gebhardt R, Kanzler S, Geier A, Breitkopf K, Weng H, Mertens PR. Hepatocyte-specific Smad7 expression attenuates TGF-beta-mediated fibrogenesis and protects against liver damage. Gastroenterology 2008; 135: 642-659
6. Inagaki Y, Higashi K, Kushida M, Hong YY, Nakao S, Higashiyama R, Moro T, Itoh J, Mikami T, Kimura T, Shiota G, Kuwabara I, Okazaki I. Hepatocyte growth factor suppresses profibrogenic signal transduction via nuclear export of Smad3 with galectin-7. Gastroenterology 2008; 134: 1180-1190 (Pubitemid 351451969)
7. Comporti M, Signorini C, Arezzini B, Vecchio D, Monaco B, Gardi C. Isoprostanes and hepatic fibrosis. Mol Aspects Med 2008; 29: 43-49
8. Dumont JM, Maignan MF, Janin B, Herbage D, Perrissoud D. Effect of malotilate on chronic liver injury induced by carbon tetrachloride in the rat. J Hepatol 1986; 3: 260-268 (Pubitemid 17173115)
9. Chen YX, Zhang XR, Xie WF, Li S. Effects of taurine on proliferation and apoptosis of hepatic stellate cells in vitro. Hepatobiliary Pancreat Dis Int 2004; 3: 106-109 (Pubitemid 38256137)
10. Kato J, Ido A, Hasuike S, Uto H, Hori T, Hayashi K, Murakami S, Terano A, Tsubouchi H. Transforming growth factor-beta-induced stimulation of formation of collagen fiber network and antifibrotic effect of taurine in an in vitro model of hepatic fibrosis. Hepatol Res 2004; 30: 34-41 (Pubitemid 39145037)
11. Nagle DG, Ferreira D, Zhou YD. Epigallocatechin-3-gallate (EGCG) : chemical and biomedical perspectives. Phytochemistry 2006; 67: 1849-1855 (Pubitemid 44291411)
12. Nakamuta M, Higashi N, Kohjima M, Fukushima M, Ohta S, Kotoh K, Kobayashi N, Enjoji M. Epigallocatechin-3-gallate, a polyphenol component of green tea, suppresses both collagen production and collagenase activity in hepatic stellate cells. Int J Mol Med 2005; 16: 677-681
13. Zhen MC, Wang Q, Huang XH, Cao LQ, Chen XL, Sun K, Liu YJ, Li W, Zhang LJ. Green tea polyphenol epigallocatechin-3-gallate inhibits oxidative damage and preventive effects on carbon tetrachloride-induced hepatic fibrosis. J Nutr Biochem 2007; 18: 795-805 (Pubitemid 350138426)
14. Gäbele E, Brenner DA, Rippe RA. Liver fibrosis: signals leading to the amplification of the fibrogenic hepatic stellate cell. Front Biosci 2003; 8: d69-d77 (Pubitemid 39069964)
15. Giannelli G, Antonaci S. Immunological and molecular aspects of liver fibrosis in chronic hepatitis C virus infection. Histol Histopathol 2005; 20: 939-944 (Pubitemid 40932611)
16. Friedman SL. Mechanisms of disease: Mechanisms of hepatic fibrosis and therapeutic implications. Nat Clin Pract Gastroenterol Hepatol 2004; 1: 98-105 (Pubitemid 40823677)
17. Tsukada S, Parsons CJ, Rippe RA. Mechanisms of liver fibrosis. Clin Chim Acta 2006; 364: 33-60
18. Yoshiji H, Kuriyama S, Miyamoto Y, Thorgeirsson UP, Gomez DE, Kawata M, Yoshii J, Ikenaka Y, Noguchi R, Tsujinoue H, Nakatani T, Thorgeirsson SS, Fukui H. Tissue inhibitor of metalloproteinases-1 promotes liver fibrosis development in a transgenic mouse model. Hepatology 2000; 32: 1248-1254
19. Murphy FR, Issa R, Zhou X, Ratnarajah S, Nagase H, Arthur MJ, Benyon C, Iredale JP. Inhibition of apoptosis of activated hepatic stellate cells by tissue inhibitor of metalloproteinase-1 is mediated via effects on matrix metalloproteinase inhibition: implications for reversibility of liver fibrosis. J Biol Chem 2002; 277: 11069-11076 (Pubitemid 34952866)